This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Transgene S.a., Bayer Aktiengesellschaft. Active years: 1997-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wurzburg, DE (1997 - 2001)
- Würzburg, DE (2001 - 2004)
Company Filing History:
Years Active: 1997-2004
Title: Innovations by Axel Rethwilm in Virology
Introduction
Axel Rethwilm, based in Wurzburg, Germany, is a notable inventor with a significant contribution to the field of virology. With a diverse portfolio of 7 patents, Rethwilm has focused on the expression of foamy virus envelope proteins, advancing both scientific understanding and pharmaceutical applications.
Latest Patents
Among his latest innovations, Rethwilm has developed constructs for the expression of a protein comprising at least a modified foamy virus (FV) envelope protein. This invention includes not only the protein obtained through his methods but also a complementation cell line that enables the production of pseudotyped viral particles. Furthermore, these innovations extend to pharmaceutical compositions comprising these particles and methods for treating various diseases, underscoring the potential impact of his work in therapeutic applications.
Career Highlights
Rethwilm has made notable strides in his career by collaborating with prominent companies in the biotechnology sector, including Transgene and Bayer Aktiengesellschaft. His work has had implications for the development of treatments and therapies, showcasing the practical applications of his inventions.
Collaborations
Throughout his career, Axel Rethwilm has worked alongside distinguished colleagues, such as Dirk Lindemann and Arend Jan Winter. These collaborations highlight the collaborative nature of innovation in research and development, where shared knowledge and expertise drive progress in the field.
Conclusion
In summary, Axel Rethwilm is a significant figure in the realm of virology innovations. His patents and collaborative efforts reflect a commitment to advancing medical science through inventive approaches in virology. As an inventor based in Wurzburg, Germany, Rethwilm continues to contribute to the evolving landscape of virology and pharmaceutical developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile